| Insider | Flanagan W. Michael |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 27, 2026 |
| Transaction Code | D Sale to Issuer |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 27, 2026 |
| Shares Purchased | 150,365 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | No |
| Accession Number | 0001193125-26-082261 |
| Document | View SEC Filing |